Table 5. Postoperative morbidity and mortality.
| Operated patients n=32 | ||||||
|---|---|---|---|---|---|---|
| |
FLO |
FLOT |
Total |
|||
| Type of complication | n=17 | % | n=15 | % | n=32 | % |
| Anastomotic leakage |
1 |
5.9 |
|
|
1 |
3.1 |
| Pulmonary (pneumonia, lung failure, pleural effusion) |
3 |
17.6 |
3 |
20.0 |
6 |
18.8 |
| Cardiovascular (myocardial infarction) |
|
|
1 |
6.7 |
1 |
3.1 |
| Bleeding |
1 |
5.9 |
1 |
6.7 |
2 |
6.3 |
| Enterothorax |
1 |
5.9 |
|
|
1 |
3.1 |
| Wound infection |
|
|
3 |
20.0 |
3 |
9.4 |
| Renal failure |
|
|
1 |
6.7 |
1 |
3.1 |
|
Total morbidity |
6 |
35.3 |
9 |
60.0 |
15 |
46.9 |
| 30-day-mortality | 0 | — | 0 | — | 0 | — |
Abbrevations: FLO=oxaliplatin, fluorouracil; FLOT=fluorouracil, oxaliplatin, docetaxel.